Question 1

What is the catalog number for FMA-Fluorescein Mercuric Acetate (>85%)?

Accepted Answer

The catalog number for FMA-Fluorescein Mercuric Acetate (>85%) is TRC-F692050-100MG.

Question 2

What sizes are available for FMA-Fluorescein Mercuric Acetate (>85%)?

Accepted Answer

FMA-Fluorescein Mercuric Acetate (>85%) is available in the following size(s): 100 mg.

Question 3

Is FMA-Fluorescein Mercuric Acetate (>85%) in stock?

Accepted Answer

FMA-Fluorescein Mercuric Acetate (>85%) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 6

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

FMA-Fluorescein Mercuric Acetate (>85%)

Product Specifications

CAS Number

Hazard Statement

Smiles

Molecular Formula

Molecular Weight

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human Lambda Light Chain (Lamb14), CF488A conjugate, 0.1mg/mL

Melanoma Marker (PNL2), CF568 conjugate, 0.1mg/mL

Anti-TRMT61A Antibody Picoband®, HRP Conjugate

Rabbit IgG (H+L), AlpHcAbs® Goat antibody (HRP)

Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker), CF640R conjugate, 0.1mg/mL

Anti-PYROXD1 Antibody Picoband® (Dylight488 Conjugate)